January 31, 2001
AmeriPath Announces Retirement of Chief Financial Officer
FOR IMMEDIATE RELEASE
Contact: Gregory A. Marsh
Vice President, Chief Financial Officer,
Secretary, & Treasurer
AmeriPath, Inc.
561-712-6211
Michelle D. Getty
Investor Relations
AmeriPath, Inc.
561-845-1850
E-mail: invrel@ameripath.com
Riviera Beach, FL, January 31, 2001 - AmeriPath Inc.,
(NASDAQ: PATH), the nation's largest company focused
on providing anatomic pathology, cancer diagnostic and
related healthcare information services, announced today
that Robert P. Wynn, Executive Vice President, Chief
Financial Officer, Secretary, and Treasurer, will be
leaving AmeriPath.
James C. New, Chairman and CEO commented, "Bob has been
with AmeriPath since its inception and was instrumental
in building our company to what it is today. We
support his decision and wish him the best of success."
Gregory A. Marsh, CPA, Vice President and Controller
has been promoted to replace Mr. Wynn as the Company's
Chief Financial Officer and Secretary & Treasurer. Mr.
Marsh joined AmeriPath in 1996 after 13 years of accounting
and financial experience with Sensormatic Electronics
Corporation and Coopers & Lybrand. He has worked
diligently to develop outstanding relationships with
our divisions, investors and banking partners. Mr.
Marsh, who has an excellent reputation internally and
externally, will take over the growth of a well-developed
organization. He will be responsible for the financial
organization as well as administration and investor relations.
AmeriPath, Inc. is the nation's largest company focused
on providing anatomic pathology, cancer diagnostic and
related healthcare information services to physicians,
hospitals, national clinical laboratories and managed
care organizations. The Company's 426 physicians
provide medical services through 42 outpatient laboratories,
224 hospital inpatient laboratories, and 64 outpatient
surgery centers in 21 states.
...........................................................................................................................
The statements contained in this
press release are "forward-looking
statements" which are based on current beliefs and expectations.
Past performance is not necessarily indicative of future
results. In addition, forward-looking statements - which
are identified by words such as "may", "should", "believe," "expect," "anticipate" and
similar expressions -- are subject to a number of risks
and uncertainties which could cause actual results to
differ materially from historical results or those expected
or anticipated. These include risks and uncertainties
relating to demand for pathology services, pricing,
federal and state regulation (and compliance), reimbursement
rates, government and third party payments, the ability
to attract, motivate, and retain pathologists, dependence
upon pathologists and contracts, the development and
expansion of managed care and national clinical lab contracts,
completion and integration of acquisitions and affiliations
(and achievement of planned or expected synergies), competitive
factors and technology. Further information regarding
risks, uncertainties and other factors that could affect
the Company's financial results, or could cause actual
results to differ materially from those expected or anticipated,
are included in the Company's Form 10-K for the year
ended December 31, 1999 and subsequent filings with the
SEC.
